• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4602291)   Today's Articles (5060)   Subscriber (49368)
For: Beken S, Hirfanoglu I, Turkyilmaz C, Altuntas N, Unal S, Turan O, Onal E, Ergenekon E, Koc E, Atalay Y. Intravenous Immunoglobulin G Treatment in ABO Hemolytic Disease of the Newborn, is it Myth or Real? Indian J Hematol Blood Transfus 2012;30:12-5. [PMID: 24554813 DOI: 10.1007/s12288-012-0186-3] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2012] [Accepted: 08/06/2012] [Indexed: 11/30/2022]  Open
Number Cited by Other Article(s)
1
Ercin S, Coskun Y, Kayas K, Kavas N, Gursoy T. Positive Direct Antiglobulin Test: Is It a Risk Factor for Significant Hyperbilirubinemia in Neonates with ABO Incompatibility? Am J Perinatol 2024;41:505-510. [PMID: 34847590 DOI: 10.1055/a-1709-5036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
2
Zheng Y, Almeyda-Alejo Y, Tumin D, Redpath NSJ, Guillen-Hernandez J. Three or four doses of intravenous immunoglobulin G treatment for isoimmune hemolytic disease: A case series and literature review. J Neonatal Perinatal Med 2024;17:153-158. [PMID: 38143377 DOI: 10.3233/npm-230070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2023]
3
Rasiah S, Jegathesan T, Campbell DM, Shah PS, Sgro MD. Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia. Pediatr Res 2023;94:2092-2097. [PMID: 37491586 PMCID: PMC10665189 DOI: 10.1038/s41390-023-02712-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/05/2023] [Revised: 06/06/2023] [Accepted: 06/19/2023] [Indexed: 07/27/2023]
4
黄 方, 何 洋, 唐 军, 张 萌, 陈 剑, 母 得. [Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn"]. ZHONGGUO DANG DAI ER KE ZA ZHI = CHINESE JOURNAL OF CONTEMPORARY PEDIATRICS 2022;24:1183-1188. [PMID: 36398541 PMCID: PMC9678070 DOI: 10.7499/j.issn.1008-8830.2205158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 05/27/2022] [Accepted: 07/25/2022] [Indexed: 06/16/2023]
5
Lieberman L, Lopriore E, Baker JM, Bercovitz RS, Christensen RD, Crighton G, Delaney M, Goel R, Hendrickson JE, Keir A, Landry D, La Rocca U, Lemyre B, Maier RF, Muniz‐Diaz E, Nahirniak S, New HV, Pavenski K, dos Santos MCP, Ramsey G, Shehata N. International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn. Br J Haematol 2022;198:183-195. [PMID: 35415922 PMCID: PMC9324942 DOI: 10.1111/bjh.18170] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2022] [Accepted: 03/16/2022] [Indexed: 01/08/2023]
6
Karabulut B, Gafil EA. Hemolysis due to Alpha-Hemolytic Enterococcus Urinary Infection: A Rare Cause of Early and Severe Unconjugated Hyperbilirubinemia in a Neonate. J Pediatr Intensive Care 2021;10:75-78. [PMID: 33585066 DOI: 10.1055/s-0040-1710055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2020] [Accepted: 03/26/2020] [Indexed: 10/24/2022]  Open
7
Jackson ME, Baker JM. Hemolytic Disease of the Fetus and Newborn: Historical and Current State. Clin Lab Med 2020;41:133-151. [PMID: 33494881 DOI: 10.1016/j.cll.2020.10.009] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
8
Sarihi R, Ahmadnejad M, Mohammadi S, Eshghi P, Herfat F, Jolharnejad S, Oodi A. Hemolytic disease of the fetus and newborn caused by anti-Hr0 in a 27-year-old female with Dc- phenotype: A case report. Transfus Apher Sci 2020;60:102913. [PMID: 32943324 DOI: 10.1016/j.transci.2020.102913] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2020] [Revised: 08/18/2020] [Accepted: 08/19/2020] [Indexed: 11/18/2022]
9
Al-Lawama M, Badran E, Elrimawi A, Bani Mustafa A, Alkhatib H. Intravenous Immunoglobulins as Adjunct Treatment to Phototherapy in Isoimmune Hemolytic Disease of the Newborn: A Retrospective Case-Control Study. J Clin Med Res 2019;11:760-763. [PMID: 31803318 PMCID: PMC6879023 DOI: 10.14740/jocmr4003] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2019] [Accepted: 09/30/2019] [Indexed: 11/11/2022]  Open
10
Keir AK, Dunn M, Callum J. Should intravenous immunoglobulin be used in infants with isoimmune haemolytic disease due to ABO incompatibility? J Paediatr Child Health 2013;49:1072-8. [PMID: 24325716 DOI: 10.1111/jpc.12440] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 04/12/2012] [Indexed: 11/30/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA